We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$4.36B
AUM Growth
+$116M
Cap. Flow
-$72.1M
Cap. Flow %
-1.65%
Top 10 Hldgs %
19.47%
Holding
217
New
12
Increased
50
Reduced
141
Closed
5

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$36M
2
BAC icon
Bank of America
BAC
+$21.3M
3
M icon
Macy's
M
+$18.1M
4
BBWI icon
Bath & Body Works
BBWI
+$16.7M
5
LOW icon
Lowe's Companies
LOW
+$16M

Top Sells

Rank Stock Value
1
ABCO
Advisory Board Co
ABCO
+$19M
2
AMGN icon
Amgen
AMGN
+$13M
3
QGEN icon
Qiagen
QGEN
+$11.8M
4
MET icon
MetLife
MET
+$9.04M
5
GLW icon
Corning
GLW
+$8.57M

Sector Composition

Rank Sector Weight
1 Financials 20.49%
2 Industrials 17.33%
3 Consumer Discretionary 13.49%
4 Technology 13.47%
5 Healthcare 11.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
176
Novo Nordisk
NVO
$208B
$354K 0.01%
14,710
-35,210
-71% -$796K
MCD icon
177
McDonald's
MCD
$192B
$353K 0.01%
2,250
VTR icon
178
Ventas
VTR
$48B
$348K 0.01%
5,340
-4,445
-45% -$300K
EPD icon
179
Enterprise Products Partners
EPD
$82.3B
$347K 0.01%
13,311
+2,910
+28% +$76.9K
GNCMA
180
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$346K 0.01%
+8,480
New +$346K
RTN
181
DELISTED
Raytheon Company
RTN
$334K 0.01%
+1,791
New +$316K
CMI icon
182
Cummins
CMI
$87.5B
$303K 0.01%
1,801
+400
+29% +$64.7K
PSX icon
183
Phillips 66
PSX
$84.9B
$291K 0.01%
3,172
+90
+3% +$7.62K
PAYX icon
184
Paychex
PAYX
$41.6B
$278K 0.01%
4,632
BIIB icon
185
Biogen
BIIB
$30B
$267K 0.01%
854
-15
-2% -$4.44K
SYK icon
186
Stryker
SYK
$125B
$261K 0.01%
1,840
-25
-1% -$3.58K
KHC icon
187
Kraft Heinz
KHC
$30.7B
$260K 0.01%
3,350
-406
-11% -$34K
SUI icon
188
Sun Communities
SUI
$15.2B
$257K 0.01%
3,000
TGT icon
189
Target
TGT
$65.6B
$257K 0.01%
4,349
+300
+7% +$16.8K
LMT icon
190
Lockheed Martin
LMT
$134B
$252K 0.01%
813
+55
+7% +$16.4K
STI
191
DELISTED
SunTrust Banks, Inc.
STI
$247K 0.01%
+4,128
New +$233K
VSM
192
DELISTED
Versum Materials, Inc.
VSM
$243K 0.01%
6,253
-7,637
-55% -$273K
WBC
193
DELISTED
WABCO HOLDINGS INC.
WBC
$237K 0.01%
1,600
CVS icon
194
CVS Health
CVS
$133B
$230K 0.01%
2,833
-311
-10% -$24.6K
GS icon
195
Goldman Sachs
GS
$300B
$226K 0.01%
954
-150
-14% -$33.8K
FNF icon
196
Fidelity National Financial
FNF
$13.9B
$215K ﹤0.01%
+6,526
New +$213K
CHTR icon
197
Charter Communications
CHTR
$17.3B
$213K ﹤0.01%
+586
New +$218K
D icon
198
Dominion Energy
D
$60.8B
$206K ﹤0.01%
2,677
-506
-16% -$39.4K
PGR icon
199
Progressive
PGR
$123B
$206K ﹤0.01%
+4,250
New +$199K
LLY icon
200
Eli Lilly
LLY
$1.02T
$203K ﹤0.01%
2,375
-808
-25% -$66.3K

Similar funds

Douglas Lane & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Douglas Lane & Associates held 217 positions worth $4.36B, up 2.7% from $4.24B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Douglas Lane & Associates's Q3 2017 filing shows 12 new, 50 increased, 141 reduced and 5 closed positions. Its largest new stake was Brighthouse Financial: 82,983 shares worth $5.04M. The largest sale was Advisory Board Co, an estimated $19M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Douglas Lane & Associates's largest Q3 2017 buy was Brighthouse Financial: 82,983 shares worth $5.04M.
  • Douglas Lane & Associates added most to Oracle in Q3 2017, an estimated $36M increase.
  • Douglas Lane & Associates's biggest Q3 2017 reduction was Advisory Board Co, cutting an estimated $19M.
  • Douglas Lane & Associates fully exited Whole Foods Market Inc in Q3 2017, selling an estimated $4.4M.
  • Douglas Lane & Associates's ten largest holdings make up 19% of its $4.36B portfolio in Q3 2017.
  • Douglas Lane & Associates opened 12 new positions and closed 5 in Q3 2017.
  • Douglas Lane & Associates's portfolio value rose 2.7% quarter-over-quarter to $4.36B.

Based on Douglas Lane & Associates's 13F filing for Q3 2017, filed 19 Oct 2017.